Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
InnoCare Pharma Ltd. ( (HK:9969) ) just unveiled an announcement.
InnoCare Pharma Limited announced that it has received a waiver from the Hong Kong Stock Exchange, allowing for a temporary extension to comply with specific listing rules following the resignation of an independent non-executive director. The company is in discussions with a potential candidate to fill the vacancy and is committed to adhering to the listing requirements promptly, signaling proactive steps to maintain compliance and stability in its governance structure.
More about InnoCare Pharma Ltd.
InnoCare Pharma Limited is a pharmaceutical company incorporated in the Cayman Islands. It focuses on the development and commercialization of innovative therapies for the treatment of cancer and autoimmune diseases, targeting the vast market for unmet medical needs.
YTD Price Performance: -15.36%
Average Trading Volume: 4,864,465
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: HK$7.75B
For a thorough assessment of 9969 stock, go to TipRanks’ Stock Analysis page.
